SCHEMBL19086870

SCHEMBL19086870

COC(=O)c1c(O)c2cc(NC(=O)c3ccccc3)ccc2n(C)c1=O

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.53
ALDH1A1 P00352 2/20 0.53
NTRK1 P04629 1/20 0.53
NGFR P08138 1/20 0.53
ALOX15 P16050 1/20 0.53
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
RAB9A P51151 3/20 0.53
SRC P12931 3/20 0.50
MAPT P10636 2/20 0.49
POLB P06746 1/20 0.49
HIF1A Q16665 2/20 0.48
KDM4E B2RXH2 1/20 0.47
NLRP3 Q96P20 1/20 0.47
EGFR P00533 1/20 0.47
PTPN1 P18031 1/20 0.46
BRD4 O60885 1/20 0.46
BRPF1 P55201 1/20 0.46
GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28211430 0.88 NTRK1 (0.54) NPC1ALDH1A1NTRK1NGFRALOX15
SCHEMBL19086549 0.84 RAB9A (0.51) NPC1ALDH1A1ALOX15MEN1KMT2A
SCHEMBL17578567 0.84 HIF1A (0.67) NPC1MEN1KMT2ARAB9AHIF1A
SCHEMBL28211409 0.83 NTRK1 (0.56) NPC1NTRK1NGFRMEN1KMT2A
SCHEMBL28825720 0.81 NTRK1 (0.53) NPC1ALDH1A1NTRK1NGFRALOX15
SCHEMBL19086664 0.78 HIF1A (0.71) ALDH1A1HIF1AKDM4EGAA
SCHEMBL1685954 0.78 ALDH1A1 (0.72) NPC1ALDH1A1ALOX15MEN1KMT2A
SCHEMBL10681489 0.78 EGFR (0.70) NPC1ALDH1A1ALOX15MEN1KMT2A
SCHEMBL19086545 0.78 HIF1A (0.52) NPC1ALDH1A1ALOX15MEN1KMT2A
SCHEMBL3390812 0.76 RAB9A (0.51) NPC1ALDH1A1MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3190104-B1 QUINOLINONE COMPOUND AND USE THEREOF SUNSHINE LAKE PHARMA CO LTD (CN) 2021-10-27 EP disclosed
US-10065928-B2 Quinolinone compound and use thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2018-09-04 US disclosed
US-20170247332-A1 QUINOLINONE COMPOUND AND USE THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2017-08-31 US disclosed
EP-3190104-A1 QUINOLINONE COMPOUND AND USE THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2017-07-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170247332-A1 QUINOLINONE COMPOUND AND USE THEREOF HIF1AN, HIF1A, EGLN2 NPC1 3765/4885ALDH1A1 517/4885NTRK1 4853/4885
US-10065928-B2 Quinolinone compound and use thereof HIF1AN, HIF1A, EGLN2 NPC1 3765/4885ALDH1A1 517/4885NTRK1 4853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.